List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 62 studies with search of: "Acromegaly"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Glucose Tolerance in Acromegaly: The Influence of GH-Excess on Glucose Metabolism and Insulin Resistance
Conditions: Acromegaly;   Diabetes;   Insulin Resistance;   Impaired Glucose Tolerance
Intervention:
2 Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly;   Pituitary Neoplasm
Intervention:
3 Active, not recruiting Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Conditions: Carcinoid Tumor;   Acromegaly
Intervention: Drug: Pasireotide
4 Not yet recruiting Use of Somatostatin Analogue Therapy as Primary Medical Treatment of Acromegaly
Condition: Acromegaly
Intervention: Drug: Somatuline Autogel
5 Recruiting Ultrasound Guided Sandostatin LAR Injection in Acromegaly
Condition: Acromegaly
Interventions: Drug: Sandostatin LAR;   Drug: Sandostatin LAR
6 Completed Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide-LAR
7 Active, not recruiting An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Pasireotide
8 Completed Safety and Efficacy of Long-Acting Repeatable Octreotide Acetate for Injectable Suspension Vs. Surgery in Treatment-naïve Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide LAR – pituitary surgery
9 Completed Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide-LAR or lanreotide;   Procedure: Transsphenoidal adenomectomy
10 Recruiting Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
Condition: Acromegaly
Interventions: Drug: Pasireotide;   Drug: Octrotide
11 Completed Acute Application of Pegvisomant and Octreotide in Acromegaly
Condition: Acromegaly
Interventions: Drug: pegvisomant;   Drug: combination with somatostatin analogue octreotide;   Drug: combination with dopamine agonist cabergoline
12 Recruiting Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
Condition: Acromegaly
Intervention:
13 Completed Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Condition: Acromegaly
Interventions: Drug: Somatuline Autogel (lanreotide acetate);   Behavioral: Home administration
14 Completed Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR
Condition: Acromegaly
Intervention: Drug: Lanreotide (Autogel formulation)
15 Recruiting Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
Conditions: Acromegaly;   Heart Failure;   Hypertrophy, Left Ventricular
Intervention: Drug: pegvisomant
16 Recruiting Physiopathology of Sodium Retention in Acromegaly
Condition: Acromegaly
Intervention: Drug: furosemide
17 Completed Prediction of Tumor Shrinkage in Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide-LAR
18 Recruiting Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide Implant;   Drug: Sandostatin LAR Depot
19 Completed A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly
Condition: Acromegaly
Interventions: Drug: Pegvisomant;   Drug: Sandostatin LAR
20 Completed Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly
Condition: Acromegaly
Intervention: Drug: Lanreotide-Autogel 120 mg

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options